Reconnecting...
View
Focused preview

Previewing LLY market-moving headlines.

Free preview shows matched headlines and locked reaction proof. Sign up free to keep this tape open; Pro unlocks full reaction cards and price paths.
Create free account No card required
Results for "LLY" · 2 matches · Last 45 days of the published feed
Clear search
Search intelligence

LLY market intelligence

Start with the matched tape, then jump to reactions, options flow, proof, or longer articles.

23:18:00
Equities High

The health care sector experiences a minor decline as Eli Lilly reveals its $2.875 billion acquisition of Merida Biosciences aimed at strengthening its immunology portfolio. Mkt cap ~$1.2T

13:01:44
Equities

At week 52, Eli Lilly (LLY) reported that Taltz and Zepbound have further enhanced the disease activity of psoriasis or psoriatic arthritis compared to Week 36, during which statistically significant improvements over Taltz alone were noted in the TOGETHER-PsO and TOGETHER-PsA studies. Mkt cap ~$1.2T